NOVO NORDISK
TOP 10 – HEALTHCARE SUPPLY CHAINS
10
NOVO NORDISK
REVENUE: US $ 42.1BN EMPLOYEES: 77,000 + CEO: LARS FRUERGAARD JØRGENSEN FOUNDED: 1989
Novo Nordisk runs a global supply chain with a mission to get life-changing treatments to patients with diabetes, obesity and rare diseases.
From lab to loading dock, the process is finely tuned. It starts with advanced ingredient production in Denmark and the US, using everything from yeast to mammalian cells.
Fill-finish sites are growing too, thanks to a 2024 Catalent acquisition that boosts capacity for high-demand injectables such as Ozempic. Its mastery of flexible packaging and cold chain logistics also make it worthy of the top 10.
WATCH NOW Unordinary drives change
16 August 2025